Pediatric Patients with Spondylolysis Have High Rates of Vitamin-D Deficiency

Marielle A Amoli1, Jeffrey R Sawyer2, R Tyler Ellis3

  • 1Nemours Children's Specialty Care, Jacksonville, Florida.

Insights

Pediatric patients diagnosed with spondylolysis often have low vitamin D levels. This study found that most young patients with spondylolysis exhibit vitamin D deficiency or insufficiency, highlighting a critical health concern.

Area of Science:

  • Orthopedics
  • Endocrinology
  • Pediatrics

Background:

  • Spondylolysis is a stress fracture in the vertebrae.
  • Vitamin D deficiency is a growing public health concern.
  • The relationship between spondylolysis and vitamin D status is not well-established.

Purpose of the Study:

  • To assess the 25-hydroxyvitamin D levels in pediatric patients with spondylolysis.
  • To determine the prevalence of vitamin D deficiency and insufficiency in this population.

Main Methods:

  • Prospective enrollment of 39 pediatric patients with confirmed spondylolysis.
  • Measurement of 25-hydroxyvitamin D levels via blood tests.
  • Categorization of vitamin D status based on established cut-off values.

Main Results:

  • The mean 25-hydroxyvitamin D level was 26 ng/ml.
  • Only 23.1% of patients had sufficient vitamin D levels (>32 ng/ml).
  • A significant majority (76.9%) had insufficient (56.4%) or deficient (20.5%) vitamin D levels.

Conclusions:

  • Pediatric patients with spondylolysis demonstrate high rates of vitamin D deficiency and insufficiency.
  • Screening for vitamin D status should be considered in pediatric patients diagnosed with spondylolysis.
  • Addressing vitamin D deficiency may play a role in the management or prevention of spondylolysis.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.8K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
191
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
209
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
168